SlideShare a Scribd company logo
1 of 1
Download to read offline
And, most of the morphine equivalents dispensed are

received by COT patients on higher dose regimens, thereby becoming
available for diversion for non-medical use.
0%
23%
45%
68%
90%
Chronic Pain Patients Using Opioids Long-term All Other Pain Patients
Percent total morphine equivalents (ME) dispensed in 2008
60 %
of total ME
dispensed
27 %
of total ME
dispensed
13 %
of total ME
dispensed
(Acute & Cancer Pain)
Average daily 

dose > 50 mg.
Average daily 

dose < 50 mg.

More Related Content

Viewers also liked

A randomized, controlled trial of fusion surgery for lumbar spinal stenosis
A randomized, controlled trial of fusion surgery for lumbar spinal stenosisA randomized, controlled trial of fusion surgery for lumbar spinal stenosis
A randomized, controlled trial of fusion surgery for lumbar spinal stenosisPaul Coelho, MD
 
Opioids for LBP Meta-Analysis JAMA
Opioids for LBP Meta-Analysis JAMAOpioids for LBP Meta-Analysis JAMA
Opioids for LBP Meta-Analysis JAMAPaul Coelho, MD
 
Opioid benzo tapering 7-28-13
Opioid benzo tapering 7-28-13Opioid benzo tapering 7-28-13
Opioid benzo tapering 7-28-13Paul Coelho, MD
 
Converting Hi Dose Agonists To Buprenorphine
Converting Hi Dose Agonists To BuprenorphineConverting Hi Dose Agonists To Buprenorphine
Converting Hi Dose Agonists To BuprenorphinePaul Coelho, MD
 
Withdrawal syndromes practice essentials, background, pathophysiology
Withdrawal syndromes  practice essentials, background, pathophysiologyWithdrawal syndromes  practice essentials, background, pathophysiology
Withdrawal syndromes practice essentials, background, pathophysiologyPaul Coelho, MD
 
Catastrophizing: Trait or State?
Catastrophizing: Trait or State?Catastrophizing: Trait or State?
Catastrophizing: Trait or State?Paul Coelho, MD
 
Pain catastrophizing scoring key.
Pain catastrophizing scoring key.Pain catastrophizing scoring key.
Pain catastrophizing scoring key.Paul Coelho, MD
 
Opioid Withdrawal Attenuation Coctail
Opioid Withdrawal Attenuation CoctailOpioid Withdrawal Attenuation Coctail
Opioid Withdrawal Attenuation CoctailPaul Coelho, MD
 
Clinical Opioid Withdrawal Scale
Clinical Opioid Withdrawal ScaleClinical Opioid Withdrawal Scale
Clinical Opioid Withdrawal ScalePaul Coelho, MD
 
Fibromyalagia Survery Questionnaire
Fibromyalagia Survery QuestionnaireFibromyalagia Survery Questionnaire
Fibromyalagia Survery QuestionnairePaul Coelho, MD
 
Opioid potencymed infographic
Opioid potencymed infographicOpioid potencymed infographic
Opioid potencymed infographicPaul Coelho, MD
 
Cost burden of chronic pain
Cost burden of chronic painCost burden of chronic pain
Cost burden of chronic painPaul Coelho, MD
 
Alternatives To Benzodiazepines
Alternatives To BenzodiazepinesAlternatives To Benzodiazepines
Alternatives To BenzodiazepinesPaul Coelho, MD
 

Viewers also liked (20)

Dast 28
Dast 28Dast 28
Dast 28
 
A randomized, controlled trial of fusion surgery for lumbar spinal stenosis
A randomized, controlled trial of fusion surgery for lumbar spinal stenosisA randomized, controlled trial of fusion surgery for lumbar spinal stenosis
A randomized, controlled trial of fusion surgery for lumbar spinal stenosis
 
2016 OMA Meeting
2016 OMA Meeting2016 OMA Meeting
2016 OMA Meeting
 
Opioids for LBP Meta-Analysis JAMA
Opioids for LBP Meta-Analysis JAMAOpioids for LBP Meta-Analysis JAMA
Opioids for LBP Meta-Analysis JAMA
 
ACE Questionnaire
ACE QuestionnaireACE Questionnaire
ACE Questionnaire
 
Opioid benzo tapering 7-28-13
Opioid benzo tapering 7-28-13Opioid benzo tapering 7-28-13
Opioid benzo tapering 7-28-13
 
PSQI
PSQIPSQI
PSQI
 
Converting Hi Dose Agonists To Buprenorphine
Converting Hi Dose Agonists To BuprenorphineConverting Hi Dose Agonists To Buprenorphine
Converting Hi Dose Agonists To Buprenorphine
 
Withdrawal syndromes practice essentials, background, pathophysiology
Withdrawal syndromes  practice essentials, background, pathophysiologyWithdrawal syndromes  practice essentials, background, pathophysiology
Withdrawal syndromes practice essentials, background, pathophysiology
 
Catastrophizing: Trait or State?
Catastrophizing: Trait or State?Catastrophizing: Trait or State?
Catastrophizing: Trait or State?
 
Pain catastrophizing scoring key.
Pain catastrophizing scoring key.Pain catastrophizing scoring key.
Pain catastrophizing scoring key.
 
Opioid Withdrawal Attenuation Coctail
Opioid Withdrawal Attenuation CoctailOpioid Withdrawal Attenuation Coctail
Opioid Withdrawal Attenuation Coctail
 
Naloxone
NaloxoneNaloxone
Naloxone
 
2005 DEA FAQ's
2005 DEA FAQ's2005 DEA FAQ's
2005 DEA FAQ's
 
PHQ-15
PHQ-15PHQ-15
PHQ-15
 
Clinical Opioid Withdrawal Scale
Clinical Opioid Withdrawal ScaleClinical Opioid Withdrawal Scale
Clinical Opioid Withdrawal Scale
 
Fibromyalagia Survery Questionnaire
Fibromyalagia Survery QuestionnaireFibromyalagia Survery Questionnaire
Fibromyalagia Survery Questionnaire
 
Opioid potencymed infographic
Opioid potencymed infographicOpioid potencymed infographic
Opioid potencymed infographic
 
Cost burden of chronic pain
Cost burden of chronic painCost burden of chronic pain
Cost burden of chronic pain
 
Alternatives To Benzodiazepines
Alternatives To BenzodiazepinesAlternatives To Benzodiazepines
Alternatives To Benzodiazepines
 

More from Paul Coelho, MD

Suicidality Poster References.docx
Suicidality Poster References.docxSuicidality Poster References.docx
Suicidality Poster References.docxPaul Coelho, MD
 
Opioid Milli-equivalence Conversion Factors CDC
Opioid Milli-equivalence Conversion Factors CDCOpioid Milli-equivalence Conversion Factors CDC
Opioid Milli-equivalence Conversion Factors CDCPaul Coelho, MD
 
Labeling Woefulness: The Social Construction of Fibromyalgia
Labeling Woefulness: The Social Construction of FibromyalgiaLabeling Woefulness: The Social Construction of Fibromyalgia
Labeling Woefulness: The Social Construction of FibromyalgiaPaul Coelho, MD
 
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...Paul Coelho, MD
 
Pain Phenotyping Tool For Primary Care
Pain Phenotyping Tool For Primary CarePain Phenotyping Tool For Primary Care
Pain Phenotyping Tool For Primary CarePaul Coelho, MD
 
Fibromyalgia & Somatic Symptom Disorder Patient Handout
Fibromyalgia & Somatic Symptom Disorder Patient HandoutFibromyalgia & Somatic Symptom Disorder Patient Handout
Fibromyalgia & Somatic Symptom Disorder Patient HandoutPaul Coelho, MD
 
Community Catastrophizing
Community CatastrophizingCommunity Catastrophizing
Community CatastrophizingPaul Coelho, MD
 
Risk-Benefit High-Dose LTOT
Risk-Benefit High-Dose LTOTRisk-Benefit High-Dose LTOT
Risk-Benefit High-Dose LTOTPaul Coelho, MD
 
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...Paul Coelho, MD
 
Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.Paul Coelho, MD
 
Jamapsychiatry santavirta 2017_oi_170084
Jamapsychiatry santavirta 2017_oi_170084Jamapsychiatry santavirta 2017_oi_170084
Jamapsychiatry santavirta 2017_oi_170084Paul Coelho, MD
 
Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...Paul Coelho, MD
 
Gao recommendations to CMS
Gao recommendations to CMSGao recommendations to CMS
Gao recommendations to CMSPaul Coelho, MD
 
Prescribing by specialty
Prescribing by specialtyPrescribing by specialty
Prescribing by specialtyPaul Coelho, MD
 
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...Paul Coelho, MD
 
Structured opioid refill clinic epic smartphrases
Structured opioid refill clinic epic smartphrases Structured opioid refill clinic epic smartphrases
Structured opioid refill clinic epic smartphrases Paul Coelho, MD
 
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...Paul Coelho, MD
 
The potential adverse influence of physicians’ words.
The potential adverse influence of physicians’ words.The potential adverse influence of physicians’ words.
The potential adverse influence of physicians’ words.Paul Coelho, MD
 
Ctaf chronic pain__evidence_report_100417
Ctaf chronic pain__evidence_report_100417Ctaf chronic pain__evidence_report_100417
Ctaf chronic pain__evidence_report_100417Paul Coelho, MD
 

More from Paul Coelho, MD (20)

Suicidality Poster References.docx
Suicidality Poster References.docxSuicidality Poster References.docx
Suicidality Poster References.docx
 
Opioid Milli-equivalence Conversion Factors CDC
Opioid Milli-equivalence Conversion Factors CDCOpioid Milli-equivalence Conversion Factors CDC
Opioid Milli-equivalence Conversion Factors CDC
 
Labeling Woefulness: The Social Construction of Fibromyalgia
Labeling Woefulness: The Social Construction of FibromyalgiaLabeling Woefulness: The Social Construction of Fibromyalgia
Labeling Woefulness: The Social Construction of Fibromyalgia
 
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
 
Pain Phenotyping Tool For Primary Care
Pain Phenotyping Tool For Primary CarePain Phenotyping Tool For Primary Care
Pain Phenotyping Tool For Primary Care
 
Fibromyalgia & Somatic Symptom Disorder Patient Handout
Fibromyalgia & Somatic Symptom Disorder Patient HandoutFibromyalgia & Somatic Symptom Disorder Patient Handout
Fibromyalgia & Somatic Symptom Disorder Patient Handout
 
Community Catastrophizing
Community CatastrophizingCommunity Catastrophizing
Community Catastrophizing
 
Risk-Benefit High-Dose LTOT
Risk-Benefit High-Dose LTOTRisk-Benefit High-Dose LTOT
Risk-Benefit High-Dose LTOT
 
Space Trial
Space TrialSpace Trial
Space Trial
 
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
 
Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.
 
Jamapsychiatry santavirta 2017_oi_170084
Jamapsychiatry santavirta 2017_oi_170084Jamapsychiatry santavirta 2017_oi_170084
Jamapsychiatry santavirta 2017_oi_170084
 
Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...
 
Gao recommendations to CMS
Gao recommendations to CMSGao recommendations to CMS
Gao recommendations to CMS
 
Prescribing by specialty
Prescribing by specialtyPrescribing by specialty
Prescribing by specialty
 
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
 
Structured opioid refill clinic epic smartphrases
Structured opioid refill clinic epic smartphrases Structured opioid refill clinic epic smartphrases
Structured opioid refill clinic epic smartphrases
 
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
 
The potential adverse influence of physicians’ words.
The potential adverse influence of physicians’ words.The potential adverse influence of physicians’ words.
The potential adverse influence of physicians’ words.
 
Ctaf chronic pain__evidence_report_100417
Ctaf chronic pain__evidence_report_100417Ctaf chronic pain__evidence_report_100417
Ctaf chronic pain__evidence_report_100417
 

Opioid reservior

  • 1. And, most of the morphine equivalents dispensed are
 received by COT patients on higher dose regimens, thereby becoming available for diversion for non-medical use. 0% 23% 45% 68% 90% Chronic Pain Patients Using Opioids Long-term All Other Pain Patients Percent total morphine equivalents (ME) dispensed in 2008 60 % of total ME dispensed 27 % of total ME dispensed 13 % of total ME dispensed (Acute & Cancer Pain) Average daily 
 dose > 50 mg. Average daily 
 dose < 50 mg.